• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Modelling the optimal target age group for seasonal influenza vaccination in Japan

tetano

Editor, Senior Moderator
Vaccine. 2019 Nov 14. pii: S0264-410X(19)31508-7. doi: 10.1016/j.vaccine.2019.11.001. [Epub ahead of print] [h=1]Modelling the optimal target age group for seasonal influenza vaccination in Japan.[/h]
Tsuzuki S[SUP]1[/SUP], Baguelin M[SUP]2[/SUP], Pebody R[SUP]3[/SUP], van Leeuwen E[SUP]3[/SUP].
[h=3]Author information[/h] 1 Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Respiratory Diseases Department, Public Health England, London, United Kingdom. Electronic address: stsuzuki@hosp.ncgm.go.jp. 2 Respiratory Diseases Department, Public Health England, London, United Kingdom; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, W2 1PG, United Kingdom; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, United Kingdom. 3 Respiratory Diseases Department, Public Health England, London, United Kingdom.

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] In Japan, the current influenza vaccination programme is targeting older individuals. On the other hand, epidemics of influenza are likely to be mainly driven by children. In this study, we consider the most cost-effective target age group for a seasonal influenza vaccination programme in Japan.
[h=4]METHODS:[/h] We constructed a deterministic compartmental Susceptible-Exposed-Infectious-Recovered (SEIR) model with data from the 2012/13 to 2014/15 influenza seasons in Japan. Bayesian inference with Markov Chain Monte Carlo method was used for parameter estimation. Cost-effectiveness analyses were conducted from public health care payer's perspective.
[h=4]RESULTS:[/h] A scenario targeting children under 15 was expected to reduce the number of cases 6,382,345 compared to the current strategy. A scenario targeting elderly population (age over 49 years) was expected to reduce the number of cases 693,206. The children targeted scenario demonstrated negative ICER (incremental cost-effectiveness ratio) value. On the other hand, elderly targeted scenario demonstrated higher ICER value than the willingness to pay (50,000 USD/QALY).
[h=4]CONCLUSIONS:[/h] A vaccination programme which targets children under 15 is predicted to have much larger epidemiological impact than those targeting elderly.
Copyright ? 2019 Elsevier Ltd. All rights reserved.


[h=4]KEYWORDS:[/h] Cost-effectiveness analysis; Influenza; Japan; Mathematical model; Vaccination policy

PMID: 31735503 DOI: 10.1016/j.vaccine.2019.11.001
 
Back
Top Bottom